Reducing Inappropriate Benzodiazepine Use Among Older Adults
2 other identifiers
interventional
44
1 country
1
Brief Summary
The goal of this project is to reduce chronic benzodiazepine use through two approaches: direct patient education or direct patient education paired with additional support and encouragement from a behavioral health care manager.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2018
CompletedFirst Posted
Study publicly available on registry
January 23, 2018
CompletedStudy Start
First participant enrolled
February 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2018
CompletedOctober 11, 2018
October 1, 2018
7 months
January 12, 2018
October 10, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Change in avg. daily dose of benzodiazepine prescribed in lorazepam-equivalent mg
Compare the average daily dose during month 3 to the baseline average daily dose
3 months
Change in avg. daily dose of benzodiazepine prescribed in lorazepam-equivalent mg
Compare the average daily dose during month 6 to the baseline average daily dose
6 months
Secondary Outcomes (8)
Patient Health Questionnaire (PHQ-8)
3 months
Generalized Anxiety Disorder 7-Item Scale (GAD-7)
3 months
Insomnia Severity Index (ISI)
3 months
Alcohol Use Disorders Identification Test (AUDIT-C)
3 months
PHQ-8
6 months
- +3 more secondary outcomes
Study Arms (2)
Educational Material with Collaborative Care available
ACTIVE COMPARATORIn addition to the material described below, these patients are seen in clinics with behavioral health collaborative care (BHCC), which includes a care manager in the primary care provider's office along with a consulting psychiatrist. If a patient receives the brochure and would like to taper their benzodiazepine, their provider can refer them to the BHCC care manager who can provide education and anxiety and insomnia self-management strategies, while the BHCC psychiatrist will make recommendations regarding the medication taper back to the primary care provider.
Educational Material Only
ACTIVE COMPARATORPatients will receive an 8-page educational brochure that presents information about potential harms of these medications and a vignette about a patient that successfully stopped. It does NOT suggest patients to stop on their own, but rather suggests they speak with their provider.
Interventions
Educational material is in the form of a brochure
Supplemental care management consist of meeting with a behavioral health care manager over five sessions in-person or via phone call; the care manager will review patient information with the consulting psychiatrist, who can then make recommendations back to the primary care provider
Eligibility Criteria
You may qualify if:
- With a prescription BZD supply covering ≥20% of days in the preceding 12 months ("chronic").
You may not qualify if:
- Patients with BZD supply \<20% days in past 12 months
- Patients with ICD-10 codes for dementia (derived from encounter diagnosis codes)
- long-term care residents (ICD-10 codes Z59.3 and Y92.199)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Psychiatry, University of Michigan
Ann Arbor, Michigan, 48109, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Donovan Maust, MS, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychiatry
Study Record Dates
First Submitted
January 12, 2018
First Posted
January 23, 2018
Study Start
February 8, 2018
Primary Completion
September 20, 2018
Study Completion
September 20, 2018
Last Updated
October 11, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share